Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The company expects to initiate Phase III trials evaluating subcutaneous VK2735 in obesity in the second quarter
Its ability to lower HbA1c levelsa measure of blood sugar control over the past two to three monthsis well-documented in clinical trials
Metformin and insulin were the established treatments for T2D in youth until the recent approval by the Food and Drug Administration (FDA) of two SGLT2 inhibitors (dapagliflozin and empagliflozin) for children and adolescents above 10 years of age with T2D, for use in combination with diet and exercise
instead, we take time to understand your needs and develop a personalized weight-loss plan that works for you
US$ 20.29
US$ 25.15
US$ 22.14
US$ 27.86
US$ 24.89
US$ 21.84
US$ 21.62
US$ 25.47
US$ 24.35
